Ipilimumab
ATC L01FX04 · 10 markets · 25 records
Ipilimumab
Forms
AU 7 records · 5 strengths
- 213 mginjectionWINGLORE ipilimumab (rch) 50mg in 10mL (5mg/mL) concentrate solution for IV infusion vialYERVOY ipilimumab (rch) 50mg in 10mL (5mg/mL) concentrate solution for IV infusion vial
- 200 mg/40 mLinjectionYERVOY
- 53.5 mginjectionWINGLORE ipilimumab (rch) 50mg in 10mL (5mg/mL) concentrate solution for IV infusion vialYERVOY ipilimumab (rch) 50mg in 10mL (5mg/mL) concentrate solution for IV infusion vial
- 50 mg/10 mLinjectionYERVOY
Records without a stated strength · 1 YERVOY
GB 4 records · 2 strengths
- 200 mg/40 mLinjectionYervoy 50mg/10ml concentrate for solution for infusion vials
- 50 mg/10 mLinjectionYervoy 50mg/10ml concentrate for solution for infusion vials
US 2 records · 1 strengths
- 5 mginjectionYERVOY
ES 2 records · 2 strengths
HK 2 records · 1 strengths
Records without a stated strength · 1 YERVOY CONCENTRATE FOR SOLUTION FOR INFUSION 200MG/40ML
CA 1 records · 1 strengths
- 5 mgliquidYERVOY
SG 1 records · 1 strengths
- 5 mg/mLinjectionYERVOY INJECTION CONCENTRATE 5MG/ML
MX 1 records · 1 strengths
Records without a stated strength · 1 YERVOY
TW 1 records · 1 strengths
- 5 mginjectionYERVOY (ipilimumab) Injection 5mg/mL益伏注射劑 5毫克/毫升
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 YERVOY
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.